Nicholas Buss is a Cardiology physician affiliated with Eli Lilly. OpenAlex indexes 54 publications with 1,033 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2500 NE Neff Rd
Bend, OR 977016015
Telephone
541-388-4333Provider last certified this registry record 19 May 2023.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- Medtronic, Inc.Program year202420 payments
- ABIOMEDProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.1%Beta blocker21.5%Metoprolol Succinate75%Carvedilol19%Metoprolol Tartrate6%Part D≥110 patientsStatin14.3%Atorvastatin Calcium46%Rosuvastatin Calcium46%Pravastatin Sodium8%Part D<11 patients+ 11 more classes in this area
Blood & clotting
11.2%Factor Xa inhibitor5.7%Eliquis84%Xarelto16%Part D<11 patientsP2Y12 inhibitor5.5%Clopidogrel100%Part D≥46 patientsMetabolism & gastrointestinal
4.2%SGLT2 inhibitor2.5%Jardiance100%Part D<11 patientsPotassium supplement1.7%Potassium Chloride100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Nonclinical strategies and considerations to enable the redosing of gene therapies
Molecular Therapy — Methods & Clinical Development
2025 - Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I
Molecular Therapy — Methods & Clinical Development
2024 - Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse model
Journal of Clinical Investigation
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Flora Sam, MD
Eli Lilly
Alessandro Biffi, MD
Eli Lilly
Ann Hake, MD
Eli Lilly
Kevin Biglan, MD
Eli Lilly
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”